Pura Vida Investments, LLC United Therapeutics Corp Transaction History

Pura Vida Investments, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$205.95 - $280.43 $18.3 Million - $24.9 Million	-88,713 Reduced 70.94%	36,333 $10.1 Million
Q3 2022 Nov 14, 2022	BUY	$203.3 - $244.17 $13.1 Million - $15.7 Million	64,396 Added 106.18%	125,046 $26.2 Million
Q2 2022 Aug 15, 2022	BUY	$174.81 - $241.14 $7.71 Million - $10.6 Million	44,089 Added 266.22%	60,650 $14.3 Million
Q1 2022 May 16, 2022	BUY	$166.16 - $213.96 $964,226 - $1.24 Million	5,803 Added 53.94%	16,561 $2.97 Million
Q4 2021 Feb 14, 2022	BUY	$184.32 - $216.08 $400,158 - $469,109	2,171 Added 25.28%	10,758 $2.33 Million
Q3 2021 Nov 15, 2021	BUY	$179.86 - $214.88 $1.54 Million - $1.85 Million	8,587 New	8,587 $1.59 Million
Q4 2019 Feb 14, 2020	SELL	$78.31 - $95.34 $3.05 Million - $3.72 Million	-39,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$76.06 - $120.81 $2.97 Million - $4.71 Million	39,000 New	39,000 $3.04 Million
Q2 2018 Aug 14, 2018	SELL	$101.14 - $118.31 $2.02 Million - $2.37 Million	-20,000 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$107.21 - $151.94 $97,453 - $138,113	-909 Reduced 4.35%	20,000 $0
Q4 2017 Feb 14, 2018	BUY	$118.58 - $151.28 $2.48 Million - $3.16 Million	20,909	20,909 $0

681

42.2M

194K

298K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.